Bicalutamide Active Not Recruiting Phase 2 Trials for Hormone-Resistant Prostate Cancer / Recurrent Prostate Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00486642Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy